Top compounds associated with response to OR4C13


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.00085 1
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC -0.00093 1
mRNA FK866 GDSC1000 pan-cancer AAC -0.00078 1
mRNA GW843682X CTRPv2 pan-cancer AAC 0.00087 1
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.00093 1
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.00065 1
mRNA IPR-456 CTRPv2 pan-cancer AAC 0.00078 1
mRNA masitinib CTRPv2 pan-cancer AAC 0.00069 1
mRNA spautin-1 CTRPv2 pan-cancer AAC -0.00066 1
mRNA cediranib CTRPv2 pan-cancer AAC 0.0008 1
Download CSV